152 related articles for article (PubMed ID: 23621252)
1. Comparison of different screening methods in estimating the prevalence of precancer and cancer amongst male inmates of a jail in maharashtra, India.
Chaudhari A; Hegde-Shetiya S; Shirahatti R; Agrawal D
Asian Pac J Cancer Prev; 2013; 14(2):859-64. PubMed ID: 23621252
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic efficiency of toluidine blue with Lugol's iodine in oral premalignant and malignant lesions.
Nagaraju K; Prasad S; Ashok L
Indian J Dent Res; 2010; 21(2):218-23. PubMed ID: 20657091
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of double vital staining with lugol's iodine and methylene blue in diagnosing superficial esophageal lesions.
Peng G; Long Q; Wu Y; Zhao J; Chen L; Li X
Scand J Gastroenterol; 2011 Apr; 46(4):406-13. PubMed ID: 21189106
[TBL] [Abstract][Full Text] [Related]
4. Toluidine blue and Lugol's iodine application in the assessment of oral malignant disease and lesions at risk of malignancy.
Epstein JB; Scully C; Spinelli J
J Oral Pathol Med; 1992 Apr; 21(4):160-3. PubMed ID: 1376363
[TBL] [Abstract][Full Text] [Related]
5. Utility of toluidine blue staining and brush biopsy in precancerous and cancerous oral lesions.
Gupta A; Singh M; Ibrahim R; Mehrotra R
Acta Cytol; 2007; 51(5):788-94. PubMed ID: 17910350
[TBL] [Abstract][Full Text] [Related]
6. A study to evaluate the efficacy of toluidine blue and cytology in detecting oral cancer and dysplastic lesions.
Rahman F; Tippu SR; Khandelwal S; Girish KL; Manjunath BC; Bhargava A
Quintessence Int; 2012 Jan; 43(1):51-9. PubMed ID: 22259809
[TBL] [Abstract][Full Text] [Related]
7. Use of Lugol's iodine in oral cancer diagnosis: an overview.
Petruzzi M; Lucchese A; Baldoni E; Grassi FR; Serpico R
Oral Oncol; 2010 Nov; 46(11):811-3. PubMed ID: 20729139
[TBL] [Abstract][Full Text] [Related]
8. Mouth self-examination to improve oral cancer awareness and early detection in a high-risk population.
Elango KJ; Anandkrishnan N; Suresh A; Iyer SK; Ramaiyer SK; Kuriakose MA
Oral Oncol; 2011 Jul; 47(7):620-4. PubMed ID: 21646040
[TBL] [Abstract][Full Text] [Related]
9. Toluidine blue staining of oral cancer and precancerous lesions.
Reddy CR; Ramulu C; Sundareshwar B; Raju MV; Gopal R; Sarma R
Indian J Med Res; 1973 Aug; 61(8):1161-4. PubMed ID: 4128319
[No Abstract] [Full Text] [Related]
10. Analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue.
Epstein JB; Silverman S; Epstein JD; Lonky SA; Bride MA
Oral Oncol; 2008 Jun; 44(6):538-44. PubMed ID: 17996486
[TBL] [Abstract][Full Text] [Related]
11. In vivo toluidine blue staining for the detection of oral cancer and precancer.
Wong PN
P N G Med J; 1982 Dec; 25(4):278-80. PubMed ID: 6191451
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of the Microlux/DLTM chemiluminescence device in screening of potentially malignant and malignant oral lesions.
Ibrahim SS; Al-Attas SA; Darwish ZE; Amer HA; Hassan MH
Asian Pac J Cancer Prev; 2014; 15(15):6081-6. PubMed ID: 25124577
[TBL] [Abstract][Full Text] [Related]
13. Value of the ViziLite Plus System as a diagnostic aid in the early detection of oral cancer/premalignant epithelial lesions.
Mojsa I; Kaczmarzyk T; Zaleska M; Stypulkowska J; Zapala-Pospiech A; Sadecki D
J Craniofac Surg; 2012 Mar; 23(2):e162-4. PubMed ID: 22446458
[TBL] [Abstract][Full Text] [Related]
14. Comparison of chemiluminescence and toluidine blue in the diagnosis of dysplasia in leukoplakia: a cross-sectional study.
Chaudhry A; Manjunath M; Ashwatappa D; Krishna S; Krishna AG
J Investig Clin Dent; 2016 May; 7(2):132-40. PubMed ID: 25532724
[TBL] [Abstract][Full Text] [Related]
15. The use of toluidine blue in the detection of pre-malignant and malignant oral lesions.
Cancela-Rodríguez P; Cerero-Lapiedra R; Esparza-Gómez G; Llamas-Martínez S; Warnakulasuriya S
J Oral Pathol Med; 2011 Apr; 40(4):300-4. PubMed ID: 21426401
[TBL] [Abstract][Full Text] [Related]
16. [Toluidine blue staining for detection of oral squamous carcinoma].
Wiersma AC; van der Waal I
Ned Tijdschr Tandheelkd; 1990 Oct; 97(10):431-2. PubMed ID: 2130265
[TBL] [Abstract][Full Text] [Related]
17. The clinicopathologic significance of small areas unstained by Lugol's iodine in the mucosa surrounding resected esophageal carcinoma: an analysis of 147 cases.
Nakanishi Y; Ochiai A; Yoshimura K; Kato H; Shimoda T; Yamaguchi H; Tachimori Y; Watanabe H; Hirohashi S
Cancer; 1998 Apr; 82(8):1454-9. PubMed ID: 9554520
[TBL] [Abstract][Full Text] [Related]
18. Reliability of toluidine blue vital staining in detection of potentially malignant oral lesions--time to reconsider.
Upadhyay J; Rao NN; Upadhyay RB; Agarwal P
Asian Pac J Cancer Prev; 2011; 12(7):1757-60. PubMed ID: 22126560
[TBL] [Abstract][Full Text] [Related]
19. [Lugol's solution in endoscopic diagnosis of early esophageal cancer].
Wang G; Zhou M; Cong Q
Zhonghua Yi Xue Za Zhi; 1995 Jul; 75(7):417-8, 446. PubMed ID: 7553162
[TBL] [Abstract][Full Text] [Related]
20. Assessing the accuracy of autofluorescence, chemiluminescence and toluidine blue as diagnostic tools for oral potentially malignant disorders--a clinicopathological evaluation.
Awan KH; Morgan PR; Warnakulasuriya S
Clin Oral Investig; 2015 Dec; 19(9):2267-72. PubMed ID: 25804887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
